The induction of oxidative stress, including the production of ROS, in tumor tissue contributes to the antitumor effects of several anticancer drugs; thus, the effect of CT administration on the antitumor action of 5-FU was investigated using a subcutaneous transplant model of CT26, which is a mouse colon cancer. Here, DDX53 is linked to neoplasm.